STK11 and cancer: The inhibition of 4E-BP1 phosphorylation that we also show here using vistusertib in the setting of STK11 deficiency will reduce expression of multiple other key molecules besides HIF-1α/GLUT1 which promote cancer cell proliferation, growth, and survival via inhibition of their cap-dependant translation34.